Navigation Links
Smoking-related colorectal cancer in older women is associated with molecularly-defined DNA changes
Date:6/29/2010

Smoking, an established risk factor for colon cancer, may induce specific epigenetic changes and gene mutations that may be involved in the development of colon cancer, according to an online study published June 29 in the Journal of The National Cancer Institute.

Cigarette smoking is a risk factor for colorectal cancer, with a recent meta-analysis estimating that people who currently smoke or smoked in the past are 18% more likely to develop colorectal cancer than non-smokers. But few studies have looked at the effect smoking may have on the specific molecular pathways of colorectal cancer. This study investigated how smoking may cause colorectal cancer at the molecular level.

To explore the molecular pathways of smoking-related colorectal cancer, Paul J. Limburg, M.D., of the Mayo Clinic, and colleagues, evaluated smoking patterns among women in the Iowa Women's Health Study (IWHS), who were between the ages of 55 and 69 years. They looked at the age at which women started smoking, the average number of cigarettes per day and per year.

The researchers sent a questionnaire to the 98,029 women enrolled in IWHS as of January 1986, to which 43% or 41,836 women responded. Non-smokers constituted 66% of the respondents, with 34% identifying themselves as active or former smokers.

The researchers found that there was only a modest association between cigarette smoking and overall colorectal cancer incidence but that smoking was strongly associated with a certain subtype of colorectal cancer, namely tumors that had high levels of microsatellite instability (MSI), epigenetic changes (alterations that do not affect the DNA sequence), and BRAF mutations.

The authors write that the results "have provided additional support that cigarette smoking is a risk factor for colorectal cancer but further indicate that the smoking-related risk may pertain to specific molecularly defined colorectal cancer subtypes that develop through epigenetically mediated carcinogenic pathways."

Furthermore, they write: "These findings indicate that epigenetic modification may be functionally involved in smoking-related colorectal carcinogenesis."

The sub-type of colorectal cancer that emerged in the study is more prevalent among older women, making them a rich sample pool for studies. However, for that same reason, the authors caution against generalizing the results to the general public.

The study could have important clinical implications: "Emerging colorectal cancer screening technologies, such as stool assays that are based on methylation markers [signs of epigenetic changes] might be particularly informative for patients with a history of prolonged tobacco use," the authors write.

In an accompanying editorial, C. Richard Boland, M.D. and Ajay Goel, Ph.D., of Baylor University Medical Center, write: "The most important message to take from the study by Limsui et al. is that colorectal cancer is a complex collection of diseases and that causation might be different for each of the categories. Cigarette smoking is associated with a specific subset of these tumors."

Boland and Goel point out that although there is a lot to understand in terms of how smoking interacts with other environmental factors, such as diet, in causing colon cancer, "the methylation pathway is particularly interesting because epigenetic changes, unlike point mutations and chromosomal rearrangements, are potentially reversible. Our task now is to understand how to translate these findings into improved screening and prevention-based strategies."


'/>"/>

Contact: Kristine Crane
jncimedia@oxfordjournals.org
301-841-1285
Journal of the National Cancer Institute
Source:Eurekalert

Related medicine news :

1. Panel calls for reducing colorectal cancer deaths by striking down barriers to screening
2. ASGE Lauds Drop in Colorectal Cancer Deaths
3. CT imaging taken post avastin may predict survival in patients with metastatic colorectal cancer
4. New England Journal of Medicine publishes CWRU review of the molecular basis of colorectal cancer
5. Selenium, Omega-3s May Stave Off Colorectal Cancer
6. Fewer left-sided colorectal tumors observed after colonoscopies
7. The Right Colorectal Cancer Test for the Right Patient
8. Life Line Screening Offers Special Pricing on Colorectal Home Test Kits in Honor of National Colorectal Cancer Month
9. A new indicator of poor prognosis in node-negative colorectal cancer patients
10. Physicians come together on National Colorectal Cancer Awareness and Screening Day
11. High weight associated with risk of colorectal tumors without microsatellite instability
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... 24, 2017 , ... HealthPostures, expert standing desk solution designer, ... built into the home office sit stand solution are bold colors, a new ... the benefits embedded in the TaskMate Go are available 24/7 through HealthPostures' online ...
(Date:2/24/2017)... ... February 24, 2017 , ... Only two months after the official release of ... in Cannes (France), XO Private has initiated a second print-run of its lavish luxury ... a metre across when open, weighs in at more than six kilos, retails at ...
(Date:2/24/2017)... ... , ... An in-depth computational analysis of genetic variants implicated in both schizophrenia ... that may explain why susceptibility to one of the disorders could place individuals at ... in the journal npj Schizophrenia. , “There is a wealth of genomic data ...
(Date:2/24/2017)... ... ... The Smart Machine Age is here, and it’s disrupting everything. Not only could it ... the United States may be taken over by technology in the next five to ... over colleagues is drawing to a close. Success will belong to those who can ...
(Date:2/24/2017)... ... February 24, 2017 , ... With ... is so critically important that we all are aware of our options and ... is proud to announce the launch of its newest edition of "Vision and ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... -- Research and Markets has announced the addition of ... report to their offering. ... The latest research Urinary Incontinence Drugs Price Analysis ... the global Urinary Incontinence market. The research answers the following ... marketed for Urinary Incontinence and their clinical attributes? How are they ...
(Date:2/23/2017)...  Cogentix Medical, Inc. (NASDAQ: CGNT), a medical device ... for the urology market, will release financial results for ... 2016 before the market open on Thursday, March 9, ... conference call and webcast to discuss its financial results ... 11:00 a.m. Eastern Time (10:00 a.m. Central Time). ...
(Date:2/23/2017)... -- Research and Markets has announced the addition of ... report to their offering. ... The latest research Oesophageal Cancer Drugs Price Analysis ... the global Oesophageal Cancer market. The research answers the ... drugs marketed for Oesophageal Cancer and their clinical attributes? How are ...
Breaking Medicine Technology: